Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Cancedda

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Science Advances|March 1, 2024
Early IGF-1 receptor inhibition in mice mimics preterm human brain disorders and reveals a therapeutic targetAlberto Potenzieri, Sara Uccella, Deborah Preiti, et al.
Cell Reports. Medicine|May 13, 2026
Traumatic life experiences during critical periods lead to diverse developmental trajectoriesGiovanni Morelli, Greta Visintin, Elisa Gelli, et al.
Frontiers in Cellular Neuroscience|September 14, 2012
Refuting the challenges of the developmental shift of polarity of GABA actions: GABA more exciting than ever!Yehezkel Ben-Ari, Melanie A Woodin, Evelyne Sernagor, et al.
Nature Communications|December 4, 2020
Modelling genetic mosaicism of neurodevelopmental disorders in vivo by a Cre-amplifying fluorescent reporterFrancesco Trovato, Riccardo Parra, Enrico Pracucci, et al.
BMJ Open|February 27, 2026
Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trialFloriana Costanzo, Valentina Maria Mongiovì, Paolo Alfieri, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Science Advances|March 1, 2024
Early IGF-1 receptor inhibition in mice mimics preterm human brain disorders and reveals a therapeutic targetAlberto Potenzieri, Sara Uccella, Deborah Preiti, et al.
Cell Reports. Medicine|May 13, 2026
Traumatic life experiences during critical periods lead to diverse developmental trajectoriesGiovanni Morelli, Greta Visintin, Elisa Gelli, et al.
Frontiers in Cellular Neuroscience|September 14, 2012
Refuting the challenges of the developmental shift of polarity of GABA actions: GABA more exciting than ever!Yehezkel Ben-Ari, Melanie A Woodin, Evelyne Sernagor, et al.
Nature Communications|December 4, 2020
Modelling genetic mosaicism of neurodevelopmental disorders in vivo by a Cre-amplifying fluorescent reporterFrancesco Trovato, Riccardo Parra, Enrico Pracucci, et al.
BMJ Open|February 27, 2026
Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trialFloriana Costanzo, Valentina Maria Mongiovì, Paolo Alfieri, et al.
Pageof 7